Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking
Pengda Qu,Shiyu Du,Wei Wang,Zhaorong Peng,Qian Hu,Haiyang Wang,Xiaohu Tang
DOI: https://doi.org/10.1097/md.0000000000036722
IF: 1.6
2024-01-11
Medicine
Abstract:Gouty arthritis (GA) is one of the most common forms of inflammatory arthritis worldwide, [ 1 ] characterized by elevated serum uric acid levels, recurrent acute arthritis, etc. [ 2–4 ] GA patients are often accompanied by diseases such as obesity, hypertension, kidney disease, cardio-cerebrovascular disease, and hyperlipidemia, which could lead to a measure of productivity loss, disability, as well as a heavy financial burden. [ 5–7 ] According to a 2017 global burden of disease study, the global prevalence rate of GA was 0.52% and the incidence rate was increasing every year. [ 8 ] It is worth noting that, in China, the prevalence and incidence rate of GA were higher than the global average. [ 9 , 10 ] Therefore, research on the treatment of GA has received increasing attention. The medications currently used to treat GA include allopurinol, febuxostat, colchicine, benzbromarone, nonsteroidal anti-inflammatory drugs, glucocorticoids, etc., according to the recommendations of the American College of Rheumatology and Chinese Society of Endorinology. [ 1 , 11 ] Although the use of the above drugs has achieved satisfactory clinical efficacy, their adverse reactions cannot be ignored, such as allopurinol-induced hypersensitivity and benzbromarone-induced explosive liver necrosis. [ 12 , 13 ] Consequently, it is necessary to find safer and more effective complementary or alternative strategies to treat GA.
medicine, general & internal